Skip to main content

Table 2 Risks of rebleeding in gastric and esophageal varices after treatment with cyanoacrylate alone or in combination with other treatments

From: Risk of rebleeding from gastroesophageal varices after initial treatment with cyanoacrylate; a systematic review and pooled analysis

Hemostasis treatment type Pooled risk of gastric varices rebleeding (confidence interval) Pooled risk of esophageal varices rebleeding (confidence interval)
Cyanoacrylate alone 0.15 (0.11–0.18) 0.29 (0.11–0.47)
Cyanoacrylate combined with ethanolamine 0.08 (0.02–0.14) 0.02 (− 0.02–0.05).
Cyanoacrylate combined with endoscopic ultrasound guided coils 0.07 (0.03–0.11)
Cyanoacrylate combined with percutaneous transhepatic variceal embolization 0.10 (0.03–0.17) a 0.16 (0.10–0.22)
Cyanoacrylate combined with transjugular intrahepatic portosystemic shunt 0.06(−0.01–0.12) a
Cyanoacrylate combined with sclerotherapy 0.10 (0.05–0.18) a 0.12 (0.04–0.20) a.
Cyanoacrylate combined with band ligation 0.10 (0.04–0.24) a
Cyanoacrylate combined with polidocanol 0.10 (0.02–0.19) a
Cyanoacrylate combined with lipiodol 0.13 (0.03–0.22) a
Cyanoacrylate combined with balloon-occluded retrograde transvenous obliteration 0.31 (0.13–0.49) b
  1. Note: The values in the table are independently calculated and the table does not mean statistical comparison between them
  2. Key: a Calculated from a single study (Not pooled); b Gastric or esophageal varices not specified (Gastroesophageal)